Skip to main content
Thomas Ollila, MD, Oncology, Providence, RI

ThomasAOllilaMD

Oncology Providence, RI

Hematologic Oncology

Physician

Dr. Ollila is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ollila's full profile

Already have an account?

  • Office

    593 Eddy St
    Providence, RI 02903
    Phone+1 401-444-9375

Education & Training

  • Brown University
    Brown UniversityResidency, Internal Medicine, 2012 - 2015
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 2012

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 2012 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Bendamustine-Rituximab Does Not Improve Survival over Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone Lymphoma
    Thomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas
    Thomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Exposure to Ibritumomab Tiuxetan and Incidence of Treatment-Related Myeloid Neoplasms Among Older Patients with B-Cell Lymphoma: A Population-Based Study
    Thomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Radiation therapy in primary testicular lymphoma (PTL): Does practice match the standard of care? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Lifespan Study Looks at Antibody Levels in Some Fully Vaccinated Cancer Patients
    Lifespan Study Looks at Antibody Levels in Some Fully Vaccinated Cancer PatientsAugust 17th, 2021